CLOSTRIDIUM DIFFICILE INFECTION IN PATIENTS WITH CANCER

Tìm thấy 10,000 tài liệu liên quan tới từ khóa "CLOSTRIDIUM DIFFICILE INFECTION IN PATIENTS WITH CANCER":

THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS MARCH 27 2017

THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS MARCH 27 2017

Bezlotoxumab (Zinplava) for Prevention of Recurrent Clostridium difficile Infection
The FDA has approved the fully human monoclonal antibody bezlotoxumab (Zinplava – Merck) for use with antibacterial drug treatment to reduce recurrence of Clostridium difficile...
Nusinersen (Spinraza) for Spinal M[r]

11 Đọc thêm

Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer

Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer

A major impediment in the treatment of ovarian cancer is the relapse of chemotherapy-resistant tumors, which occurs in approximately 25% of patients. A better understanding of the biological mechanisms underlying chemotherapy resistance will improve treatment efficacy through genetic testing and nov[r]

Đọc thêm

Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells

MODULATION OF SIRT3 EXPRESSION THROUGH CDK4/6 ENHANCES THE ANTI-CANCER EFFECT OF SORAFENIB IN HEPATOCELLULAR CARCINOMA CELLS

Hepatocellular carcinoma (HCC) is the leading cause of cancer-related deaths worldwide. The only drug currently approved for clinical use in the treatment of advanced HCC is sorafenib. However, many patients with HCC show reduced sensitivity to sorafenib during treatment.

15 Đọc thêm

SIP SMART: A parallel group randomised feasibility trial of a tailored pre-treatment swallowing intervention package compared with usual care for patients with head and neck cancer

SIP SMART: A PARALLEL GROUP RANDOMISED FEASIBILITY TRIAL OF A TAILORED PRE-TREATMENT SWALLOWING INTERVENTION PACKAGE COMPARED WITH USUAL CARE FOR PATIENTS WITH HEAD AND NECK CANCER

Dysphagia or difficulty in swallowing affects quality of life for most patients with head and neck cancer. SIP SMART – [Swallowing Intervention Package: Self-Monitoring, Assessment, Rehabilitation Training] aims to improve post-treatment swallowing outcomes through a targeted and tailored pre-treatm[r]

13 Đọc thêm

Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced nonsmall cell lung cancer: A meta-analysis

Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced nonsmall cell lung cancer: A meta-analysis

The prognostic significance of TP53 concurrent mutations in patients with epidermal growth factor receptor (EGFR)- or anaplastic lymphoma kinase (ALK)- mutated advanced non–small-cell lung cancer (NSCLC) who received EGFR-tyrosine kinase inhibitors (TKIs) or ALK-TKIs based targeted therapy remains c[r]

Đọc thêm

Knowledge, attitude related to cervical cancer screening among women

KNOWLEDGE, ATTITUDE RELATED TO CERVICAL CANCER SCREENING AMONG WOMEN

Cervical cancer mainly caused by human papilloma virus infection, is the leading cancer in Indian women and the second most common cancer in women worldwide. Almost 80% of cases occurred in developing countries. The objectives of the study were to assess the knowledge, attitude regarding cervical ca[r]

8 Đọc thêm

3’UTR polymorphism of Thymidylate Synthase gene increased the risk of persistence of pre-neoplastic cervical lesions

3’UTR polymorphism of Thymidylate Synthase gene increased the risk of persistence of pre-neoplastic cervical lesions

Cervical cancer is caused by high-risk Human Papillomavirus (hr-HPV) infection associated with cofactors that has been analyzed as predictors of the remission or persistence of cytological abnormalities remission or persistence.

Đọc thêm

Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples

Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples

Correct identification of the EGFR c.2369C>T p.(Thr790Met) variant is key to decide on a targeted therapeutic strategy for patients with acquired EGFR TKI resistance in non-small cell lung cancer. The aim of this study was to evaluate the correct detection of this variant in 12 tumor tissue specimen[r]

Đọc thêm

Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib

TUMOR ENDOTHELIAL ELTD1 AS A PREDICTIVE MARKER FOR TREATMENT OF RENAL CANCER PATIENTS WITH SUNITINIB

Patients with metastatic renal cell cancer (mRCC) are commonly treated with the tyrosine kinase inhibitor sunitinib, which blocks signalling from vascular endothelial growth factor (VEGF) - and platelet-derived growth factor-receptors, inhibiting development of new blood vessels.

8 Đọc thêm

A study of prevalence of hepatitis-B and hepatitis-C infection in thalassemic patients in a tertiary care hospital, Jamnagar, Gujarat, India

A study of prevalence of hepatitis-B and hepatitis-C infection in thalassemic patients in a tertiary care hospital, Jamnagar, Gujarat, India

Thalassemia is an autosomal recessive disease causing haemolytic anaemia. The ideal treatment of these patients involves regular, 2-4 weekly blood transfusions. The major complications by this treatment are the transmission of transfusion acquired infections such as Hepatitis B virus infection, Hepa[r]

Đọc thêm

Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with

CLINICAL UTILITY OF POLYETHYLENE GLYCOL CONJUGATED GRANULOCYTE COLONY-STIMULATING FACTOR (PEG-G-CSF) FOR PREVENTING SEVERE NEUTROPENIA IN METASTATIC COLORECTAL CANCER PATIENTS TREATED WITH

This study aimed to evaluate the efficacy and the safety of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing neutropenia in metastatic colorectal cancer (mCRC) patients that received fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) plus[r]

9 Đọc thêm

NGHIÊN CỨU KẾT QUẢ SÀNG LỌC PHÁT HIỆN UNG THƯ PHỔI Ở ĐỐI TƯỢNG TRÊN 60 TUỔI CÓ YẾU TỐ NGUY CƠ BẰNG CHỤP CẮT LỚP VI TÍNH LIỀU THẤP (TT ANH)

NGHIÊN CỨU KẾT QUẢ SÀNG LỌC PHÁT HIỆN UNG THƯ PHỔI Ở ĐỐI TƯỢNG TRÊN 60 TUỔI CÓ YẾU TỐ NGUY CƠ BẰNG CHỤP CẮT LỚP VI TÍNH LIỀU THẤP (TT ANH)

INTRODUCTION OF THESIS

1. Background:
Lung cancer is one of the common cancers. The disease has the highest incidence and mortality among cancers, most commonly seen in the elderly especially over 60 years old. The majority of lung cancer is related to secondhand and passive smoking and has over[r]

Đọc thêm

NONINVASIVE VENTILATION

NON INVASIVE VENTILATION

with higher inspiratory concentration of CO2, which decreased at increasing flow rates [5].Similar findings were reported in a bench and healthy volunteers study with an increase ininspired concentration of CO2 when the gas flow rate was reduced below 30 l/min. It isnoteworthy t[r]

388 Đọc thêm

A study of the mechanisms of immunity to pasteurella haemolytica infection

A STUDY OF THE MECHANISMS OF IMMUNITY TO PASTEURELLA HAEMOLYTICA INFECTION

... with limited infection of animals SPF lambs, advantages availability animals experimental particular haemolytica have would ready in animals P of animal animals sheep, of in haemolytica P with proved... number and costly A model seasonal laboratory low and cost infection of available the small a[r]

297 Đọc thêm

Evaluation of changes of dopamine plasma concentration in parkinson s disease patients

Evaluation of changes of dopamine plasma concentration in parkinson s disease patients

To investigate the alterations in plasma concentration of dopamine in patients with Parkinson’s disease. Subjects and methods: Changes in plasma concentration of dopamine were analyzed to find its correlations and clinical features in 45 patients with Parkinson’s disease (PD group) and 40 healthy pe[r]

Đọc thêm

Tumor characteristics, treatments, and survival outcomes in prostate cancer patients with a PSA level < 4 ng/ml: A population-based study

Tumor characteristics, treatments, and survival outcomes in prostate cancer patients with a PSA level < 4 ng/ml: A population-based study

In conclusion, PCa patients with a PSA level < 4 ng/ml have more favorable tumor characteristics at diagnosis and receive more benefit from active treatment. However, those patients with advanced TNM stage and high Gleason grade should be paid more attention in clinical application.

Đọc thêm

A survey of plasma testosterone concentration in male patients with chronic kidney disease stage III - V

A SURVEY OF PLASMA TESTOSTERONE CONCENTRATION IN MALE PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE III - V

To evaluate the plasma testosterone level in male patients with chronic kidney disease stage III - V, pre-dialysis. Subjects and methods: A cross-sectional study with a study group of 118 chronic kidney disease patients, pre-dialysis.

7 Đọc thêm

CẬP NHẬT VỀ PHÒNG NGỪA ĐỘT QUỴ CHO BỆNH NHÂN RUNG NHĨ PGS TRƯƠNG QUANG BÌNH

CẬP NHẬT VỀ PHÒNG NGỪA ĐỘT QUỴ CHO BỆNH NHÂN RUNG NHĨ PGS TRƯƠNG QUANG BÌNH

Atrial FibrillationSymptomatic AF:Only “the tip of the Iceberg”Symptomatic AFSilent AFRung nhĩ làm tăng tỷ lệ tử vong&amp; nguy cơ ĐQ tái phátTử VongCumulative probability of recurrence (%)• 3,530 patients with first-ever ischaemic stroke• AF was confirmed by ECG in 869 p[r]

37 Đọc thêm

HPV E6 and E7 oncoproteins cooperatively alter the expression of Disc Large 1 polarity protein in epithelial cells

HPV E6 and E7 oncoproteins cooperatively alter the expression of Disc Large 1 polarity protein in epithelial cells

Persistent infection with high-risk Human Papillomavirus (HPVs) is associated with the development of cervical cancer. The transforming capacity of these viruses relies on the cooperative action of the E6 and E7 viral oncoproteins.

Đọc thêm

EGFR mutation testing and treatment decisions in patients progressing on firstor second-generation epidermal growth factor receptor tyrosine kinase inhibitors

EGFR mutation testing and treatment decisions in patients progressing on firstor second-generation epidermal growth factor receptor tyrosine kinase inhibitors

The objective of this study was to investigate real-world EGFR mutation testing in patients with metastatic non-small cell lung cancer (NSCLC) upon progression on first−/second-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKI), and subsequent treatments received.

Đọc thêm

Cùng chủ đề